Capital Markets Day 21 Oct
The virtual Capital Markets Day consisted of presentations from Ascelia Pharma executives and a US Commercialization expert. This was followed by a live Q&A webcast. Links to the presentations are found further down on this page.
A replay of the live webcast can be seen in the player below
Presentations for the day
Strategic direction for Ascelia Pharma and building long-term value.
Commercial outlook for Mangoral with upgraded estimate of the addressable market and preparations for launch
The unmet medical need targeted by Mangoral and the ongoing Phase 3 study